000			02182 a2200625 4500
005			20250516034228.0
264		0	_c20120918
008			201209s 0 0 eng d
022			_a1559-131X
024	7		_a10.1007/s12032-011-9964-2 _2doi
040			_aNLM _beng _cNLM
100	1		_aWang, Shusen
245	0	0	_aClassical CMF regimen as adjuvant chemotherapy for triple-negative breast cancer may be more effective compared with anthracycline or taxane-based regimens. _h[electronic resource]
260			_bMedical oncology (Northwood, London, England) _cJun 2012
300			_a547-53 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAnthracyclines _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xtherapeutic use
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use
650	0	4	_aBreast Neoplasms _xdrug therapy
650	0	4	_aBridged-Ring Compounds _xtherapeutic use
650	0	4	_aCyclophosphamide _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aFluorouracil _xtherapeutic use
650	0	4	_aFollow-Up Studies
650	0	4	_aHumans
650	0	4	_aImmunoenzyme Techniques
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aNeoplasm Staging
650	0	4	_aPrognosis
650	0	4	_aReceptor, ErbB-2 _xmetabolism
650	0	4	_aReceptors, Estrogen _xmetabolism
650	0	4	_aReceptors, Progesterone _xmetabolism
650	0	4	_aRetrospective Studies
650	0	4	_aSurvival Rate
650	0	4	_aTaxoids _xtherapeutic use
650	0	4	_aYoung Adult
700	1		_aShi, Yanxia
700	1		_aYuan, Zhongyu
700	1		_aWang, Xi
700	1		_aLiu, Donggen
700	1		_aPeng, Roujun
700	1		_aTeng, Xiaoyu
700	1		_aQin, Tao
700	1		_aPeng, Jiewen
700	1		_aLin, Guinan
700	1		_aJiang, Xiaomei
773	0		_tMedical oncology (Northwood, London, England) _gvol. 29 _gno. 2 _gp. 547-53
856	4	0	_uhttps://doi.org/10.1007/s12032-011-9964-2 _zAvailable from publisher's website
999			_c20792979 _d20792979